ArticleTropical animal health and production2025
Therapeutic evaluation of Buparvaquone and Peganum harmala against theileriosis in cattle.
Article in Tropical animal health and production, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medicinal plants as biological and socio-ecological components of One Health.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theileriosis is a common tick borne hemoprotozoan disease of cattle in India and the World. Currently, Buparvaquone is the most commonly used drug for the treatment and prevention of Theileriosis in Bovines. However, recent reports of Buparvaquone resistance have been made in several endemic regions. This study aimed to evaluate clinical, hematological and biochemical alterations in Theileriosis infected cattle and compared the efficacy of Peganum harmala and P. harmala along with Oxytetracycline with Buparvaquone. The cattle were screened and 18 Theileriosis positive cases were selected based on thin blood smear examination which were randomly divided into three groups (n = 6). Group I was treated with inj. Buparvaquone @ 2.5 mg/kg BW IM, group II was treated with P. harmala @ 7 mg/kg BW IM and group III was treated with P. harmala @ 7 mg/kg BW IM along with inj. Oxytetracycline @ 20 mg/kg BW IV. All the infected cattle were treated with specific and supportive therapy along with vitamin B - complex for 3 days. Theileriosis infected cattle showed tick infestation, swollen lymph nodes, fever, pale mucous membrane, anorexia, nasal discharge, dullness, depression and weakness. All three groups showed significant (P < 0.05) improvement after treatments in clinical parameters (heart rate, rectal temperature and respiratory rate), hemato-biochemical parameters (total erythrocyte count, packed cell volume, absolute neutrophil, absolute monocyte, total protein, globulin, ALT, AST, BUN and creatinine) and reduction in parasitemia indicating promising effect against Theileria parasite. Group I, II and III showed 100%, 66.66% and 83.33% therapeutic efficacy respectively against theileriosis. Hence, Peganum harmala @ 7 mg/kg BW IM can be used for treatment of Theileriosis in cattle.
Indexed as
Identifiers
41269390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.